No major effect of eGFR dip on reduction of incident or worsening nephropathy by SGLT2i - PACE-CME

No major effect of eGFR dip on reduction of incident or worsening nephropathy by SGLTi

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
AHA 2024
SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
- Shawna Nesbitt, MD
Definition and staging of CKM syndrome
Definition and staging of CKM syndrome
MinuteCE®
Definition and staging of CKM syndrome
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
1.00 program credit
Case-based learning and future directions
Case-based learning and future directions
MinuteCE®
Case-based learning and future directions
1.00 program credit
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Muthiah Vaduganathan, MD, MPH
- Jurgen Floege MD
1.00 program credit
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD